Usaf ea-1 en es it fr

Usaf ea-1 Brand names, Usaf ea-1 Analogs

Usaf ea-1 Brand Names Mixture

  • No information avaliable

Usaf ea-1 Chemical_Formula


Usaf ea-1 RX_link

Usaf ea-1 fda sheet

Usaf ea-1 msds (material safety sheet)

Usaf_ea-1 MSDS

Usaf ea-1 Synthesis Reference

No information avaliable

Usaf ea-1 Molecular Weight

225.158 g/mol

Usaf ea-1 Melting Point

255 oC

Usaf ea-1 H2O Solubility

40 mg/L

Usaf ea-1 State


Usaf ea-1 LogP


Usaf ea-1 Dosage Forms

Tablets; Liquid

Usaf ea-1 Indication

For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.

Usaf ea-1 Pharmacology

Furoxone has a broad antibacterial spectrum covering the majority of gastrointestinal tract pathogens including E. coli, staphylococci, Salmonella, Shigella, Proteus, Aerobacter aerogenes, Vibrio cholerae and Giardia lamblia. Its bactericidal activity is based upon its interference with DNA replication and protein production; this antimicrobial action minimizes the development of resistant organisms.

Usaf ea-1 Absorption

Radiolabeled drug studies indicate that furazolidone is well absorbed following oral administration

Usaf ea-1 side effects and Toxicity

Reactions to Furoxone have been reported including a fall in blood pressure, urticaria, fever, arthralgia, and a vesicular morbilliform rash. Other adverse effects can include a brown discoloration of the urine; hemolysis can occur in G6PDH-deficient patients. The drug has a monoamine oxidase (MAO) inhibitory effect and should never be given concurrently to individuals already taking MAO inhibitors.

Usaf ea-1 Patient Information

No information avaliable

Usaf ea-1 Organisms Affected

Microbes (bacteria, parasites)